Report Detail

Request for Sample of this report

Chemical & Material Global Lestaurtinib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4512636
    • |
  • 16 February, 2023
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

Lestaurtinib inhibits JAK2, FLT3, and TrkA with IC50s of 0.9, 3, and less than 25 nM, respectively. Lestaurtinib is a multi-kinase inhibitor. It also has effective activity against the Trk family of receptor tyrosine kinases.
According to our (Global Info Research) latest study, the global Lestaurtinib market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Lestaurtinib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lestaurtinib market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Lestaurtinib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Lestaurtinib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Lestaurtinib market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lestaurtinib
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lestaurtinib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Techne, Cayman Chemical, APExBIO Technology, Abcam and BioVision, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Lestaurtinib market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Market segment by Application
Research
Medical
Major players covered
Bio-Techne
Cayman Chemical
APExBIO Technology
Abcam
BioVision
Merck
Selleck Chemicals
BOC Sciences
TargetMol
MyBiosource
Creative Enzymes
Focus Biomolecules
Hello Bio
Santa Cruz Biotechnology
Biorbyt
StressMarq Biosciences
BioCrick BioTech
Clearsynth
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lestaurtinib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lestaurtinib, with price, sales, revenue and global market share of Lestaurtinib from 2018 to 2023.
Chapter 3, the Lestaurtinib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lestaurtinib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Lestaurtinib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lestaurtinib.
Chapter 14 and 15, to describe Lestaurtinib sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Lestaurtinib
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Lestaurtinib Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Min Purity Less Than 98%
    • 1.3.3 Min Purity 98%-99%
    • 1.3.4 Min Purity More Than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Lestaurtinib Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medical
  • 1.5 Global Lestaurtinib Market Size & Forecast
    • 1.5.1 Global Lestaurtinib Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Lestaurtinib Sales Quantity (2018-2029)
    • 1.5.3 Global Lestaurtinib Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Bio-Techne
    • 2.1.1 Bio-Techne Details
    • 2.1.2 Bio-Techne Major Business
    • 2.1.3 Bio-Techne Lestaurtinib Product and Services
    • 2.1.4 Bio-Techne Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Bio-Techne Recent Developments/Updates
  • 2.2 Cayman Chemical
    • 2.2.1 Cayman Chemical Details
    • 2.2.2 Cayman Chemical Major Business
    • 2.2.3 Cayman Chemical Lestaurtinib Product and Services
    • 2.2.4 Cayman Chemical Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Cayman Chemical Recent Developments/Updates
  • 2.3 APExBIO Technology
    • 2.3.1 APExBIO Technology Details
    • 2.3.2 APExBIO Technology Major Business
    • 2.3.3 APExBIO Technology Lestaurtinib Product and Services
    • 2.3.4 APExBIO Technology Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 APExBIO Technology Recent Developments/Updates
  • 2.4 Abcam
    • 2.4.1 Abcam Details
    • 2.4.2 Abcam Major Business
    • 2.4.3 Abcam Lestaurtinib Product and Services
    • 2.4.4 Abcam Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Abcam Recent Developments/Updates
  • 2.5 BioVision
    • 2.5.1 BioVision Details
    • 2.5.2 BioVision Major Business
    • 2.5.3 BioVision Lestaurtinib Product and Services
    • 2.5.4 BioVision Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 BioVision Recent Developments/Updates
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck Lestaurtinib Product and Services
    • 2.6.4 Merck Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Merck Recent Developments/Updates
  • 2.7 Selleck Chemicals
    • 2.7.1 Selleck Chemicals Details
    • 2.7.2 Selleck Chemicals Major Business
    • 2.7.3 Selleck Chemicals Lestaurtinib Product and Services
    • 2.7.4 Selleck Chemicals Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Selleck Chemicals Recent Developments/Updates
  • 2.8 BOC Sciences
    • 2.8.1 BOC Sciences Details
    • 2.8.2 BOC Sciences Major Business
    • 2.8.3 BOC Sciences Lestaurtinib Product and Services
    • 2.8.4 BOC Sciences Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 BOC Sciences Recent Developments/Updates
  • 2.9 TargetMol
    • 2.9.1 TargetMol Details
    • 2.9.2 TargetMol Major Business
    • 2.9.3 TargetMol Lestaurtinib Product and Services
    • 2.9.4 TargetMol Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 TargetMol Recent Developments/Updates
  • 2.10 MyBiosource
    • 2.10.1 MyBiosource Details
    • 2.10.2 MyBiosource Major Business
    • 2.10.3 MyBiosource Lestaurtinib Product and Services
    • 2.10.4 MyBiosource Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 MyBiosource Recent Developments/Updates
  • 2.11 Creative Enzymes
    • 2.11.1 Creative Enzymes Details
    • 2.11.2 Creative Enzymes Major Business
    • 2.11.3 Creative Enzymes Lestaurtinib Product and Services
    • 2.11.4 Creative Enzymes Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Creative Enzymes Recent Developments/Updates
  • 2.12 Focus Biomolecules
    • 2.12.1 Focus Biomolecules Details
    • 2.12.2 Focus Biomolecules Major Business
    • 2.12.3 Focus Biomolecules Lestaurtinib Product and Services
    • 2.12.4 Focus Biomolecules Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Focus Biomolecules Recent Developments/Updates
  • 2.13 Hello Bio
    • 2.13.1 Hello Bio Details
    • 2.13.2 Hello Bio Major Business
    • 2.13.3 Hello Bio Lestaurtinib Product and Services
    • 2.13.4 Hello Bio Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Hello Bio Recent Developments/Updates
  • 2.14 Santa Cruz Biotechnology
    • 2.14.1 Santa Cruz Biotechnology Details
    • 2.14.2 Santa Cruz Biotechnology Major Business
    • 2.14.3 Santa Cruz Biotechnology Lestaurtinib Product and Services
    • 2.14.4 Santa Cruz Biotechnology Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Santa Cruz Biotechnology Recent Developments/Updates
  • 2.15 Biorbyt
    • 2.15.1 Biorbyt Details
    • 2.15.2 Biorbyt Major Business
    • 2.15.3 Biorbyt Lestaurtinib Product and Services
    • 2.15.4 Biorbyt Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Biorbyt Recent Developments/Updates
  • 2.16 StressMarq Biosciences
    • 2.16.1 StressMarq Biosciences Details
    • 2.16.2 StressMarq Biosciences Major Business
    • 2.16.3 StressMarq Biosciences Lestaurtinib Product and Services
    • 2.16.4 StressMarq Biosciences Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 StressMarq Biosciences Recent Developments/Updates
  • 2.17 BioCrick BioTech
    • 2.17.1 BioCrick BioTech Details
    • 2.17.2 BioCrick BioTech Major Business
    • 2.17.3 BioCrick BioTech Lestaurtinib Product and Services
    • 2.17.4 BioCrick BioTech Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 BioCrick BioTech Recent Developments/Updates
  • 2.18 Clearsynth
    • 2.18.1 Clearsynth Details
    • 2.18.2 Clearsynth Major Business
    • 2.18.3 Clearsynth Lestaurtinib Product and Services
    • 2.18.4 Clearsynth Lestaurtinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Clearsynth Recent Developments/Updates

3 Competitive Environment: Lestaurtinib by Manufacturer

  • 3.1 Global Lestaurtinib Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Lestaurtinib Revenue by Manufacturer (2018-2023)
  • 3.3 Global Lestaurtinib Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Lestaurtinib by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Lestaurtinib Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Lestaurtinib Manufacturer Market Share in 2022
  • 3.5 Lestaurtinib Market: Overall Company Footprint Analysis
    • 3.5.1 Lestaurtinib Market: Region Footprint
    • 3.5.2 Lestaurtinib Market: Company Product Type Footprint
    • 3.5.3 Lestaurtinib Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Lestaurtinib Market Size by Region
    • 4.1.1 Global Lestaurtinib Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Lestaurtinib Consumption Value by Region (2018-2029)
    • 4.1.3 Global Lestaurtinib Average Price by Region (2018-2029)
  • 4.2 North America Lestaurtinib Consumption Value (2018-2029)
  • 4.3 Europe Lestaurtinib Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Lestaurtinib Consumption Value (2018-2029)
  • 4.5 South America Lestaurtinib Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Lestaurtinib Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Lestaurtinib Sales Quantity by Type (2018-2029)
  • 5.2 Global Lestaurtinib Consumption Value by Type (2018-2029)
  • 5.3 Global Lestaurtinib Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Lestaurtinib Sales Quantity by Application (2018-2029)
  • 6.2 Global Lestaurtinib Consumption Value by Application (2018-2029)
  • 6.3 Global Lestaurtinib Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Lestaurtinib Sales Quantity by Type (2018-2029)
  • 7.2 North America Lestaurtinib Sales Quantity by Application (2018-2029)
  • 7.3 North America Lestaurtinib Market Size by Country
    • 7.3.1 North America Lestaurtinib Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Lestaurtinib Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Lestaurtinib Sales Quantity by Type (2018-2029)
  • 8.2 Europe Lestaurtinib Sales Quantity by Application (2018-2029)
  • 8.3 Europe Lestaurtinib Market Size by Country
    • 8.3.1 Europe Lestaurtinib Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Lestaurtinib Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Lestaurtinib Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Lestaurtinib Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Lestaurtinib Market Size by Region
    • 9.3.1 Asia-Pacific Lestaurtinib Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Lestaurtinib Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Lestaurtinib Sales Quantity by Type (2018-2029)
  • 10.2 South America Lestaurtinib Sales Quantity by Application (2018-2029)
  • 10.3 South America Lestaurtinib Market Size by Country
    • 10.3.1 South America Lestaurtinib Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Lestaurtinib Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Lestaurtinib Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Lestaurtinib Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Lestaurtinib Market Size by Country
    • 11.3.1 Middle East & Africa Lestaurtinib Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Lestaurtinib Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Lestaurtinib Market Drivers
  • 12.2 Lestaurtinib Market Restraints
  • 12.3 Lestaurtinib Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Lestaurtinib and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Lestaurtinib
  • 13.3 Lestaurtinib Production Process
  • 13.4 Lestaurtinib Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Lestaurtinib Typical Distributors
  • 14.3 Lestaurtinib Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Lestaurtinib. Industry analysis & Market Report on Lestaurtinib is a syndicated market report, published as Global Lestaurtinib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Lestaurtinib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,724.84
    		4,087.26
    		5,449.68
    		3,205.08
    		4,807.62
    		6,410.16
    		545,907.60
    		818,861.40
    		1,091,815.20
    		289,362.00
    		434,043.00
    		578,724.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo